{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:29:16Z","timestamp":1793089756857,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research & Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbc.2025.110486","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:42:52Z","timestamp":1752680572000},"page":"110486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of novel mitochondrial pyruvate carrier inhibitors for breast cancer treatment"],"prefix":"10.1016","volume":"301","author":[{"given":"Tanner J.","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Rumbley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor T.","family":"Ronayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatram R.","family":"Mereddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110486_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110486_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrclinonc.2017.1","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.110486_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/03008207.2015.1066780","article-title":"Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity","volume":"56","author":"Albini","year":"2015","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.jbc.2025.110486_bib4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110486_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110486_bib6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4161\/cc.24092","article-title":"Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer","volume":"12","author":"Curry","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2025.110486_bib8","first-page":"57813","article-title":"The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy","volume":"5","author":"Fu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2025.110486_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4331\/wjbc.v6.i3.148","article-title":"Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse Warburg effect and its therapeutic implication","volume":"6","author":"Lee","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110486_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond","volume":"121","author":"Ganapathy","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2025.110486_bib10","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.18632\/oncotarget.2367","article-title":"Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors","volume":"5","author":"Alvero","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2025.110486_bib11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.14348\/molcells.2016.0310","article-title":"Cancer metabolism: fueling more than just growth","volume":"39","author":"Lee","year":"2016","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jbc.2025.110486_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2013.09.017","article-title":"Evolutionary dynamics of the Warburg effect: glycolysis as a collective action problem among cancer cells","volume":"341","author":"Archetti","year":"2014","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jbc.2025.110486_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbabio.2010.08.010","article-title":"The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression","volume":"1807","author":"Diaz-Ruiz","year":"2011","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.jbc.2025.110486_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000375435","article-title":"Warburg effect or reverse warburg effect? a review of cancer metabolism","volume":"38","author":"Xu","year":"2015","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.jbc.2025.110486_bib16","first-page":"2436","article-title":"The mitochondrial pyruvate carrier in health and disease: to carry or not to carry?","volume":"1863","author":"Bender","year":"2016","journal-title":"Mol. Cell Res."},{"key":"10.1016\/j.jbc.2025.110486_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.2018100785","article-title":"The yeast mitochondrial pyruvate carrier is a hetero-dimer in its functional state","volume":"38","author":"Tavoulari","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.110486_bib18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41467-018-03525-0","article-title":"Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects","volume":"9","author":"Corbet","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110486_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/acsmedchemlett.5b00049","article-title":"Monocarboxylate transporter 1 inhibitors as potential anticancer agents","volume":"6","author":"Gurrapu","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2025.110486_bib20","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1016\/j.bmcl.2016.05.054","article-title":"Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: in vitro and in vivo studies as potential anticancer agents","volume":"26","author":"Gurrapu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2025.110486_bib21","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.18632\/oncotarget.26760","article-title":"Novel N, N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors","volume":"10","author":"Jonnalagadda","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2025.110486_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1158\/1535-7163.MCT-13-0653","article-title":"Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not Efflux","volume":"13","author":"Draoui","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2025.110486_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41586-025-08667-y","article-title":"Structure of mitochondrial pyruvate carrier and its inhibition mechanism","volume":"641","author":"He","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110486_bib24","article-title":"Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism","volume":"70","author":"Ferguson","year":"2023","journal-title":"Mol. Met."},{"key":"10.1016\/j.jbc.2025.110486_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neo.2015.08.005","article-title":"Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment","volume":"17","author":"Simoes","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2025.110486_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaf008","article-title":"Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma","volume":"27","author":"Martell","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.jbc.2025.110486_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jbc.2025.110486_bib28","series-title":"Dassault Systemes, Discovery Studio Visualizer, v.2.1.0.23298","year":"2023"},{"key":"10.1016\/j.jbc.2025.110486_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3565(24)36999-X","article-title":"The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data","volume":"283","author":"Obach","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825023361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825023361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:26:31Z","timestamp":1772792791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825023361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0021925825023361"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110486","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel mitochondrial pyruvate carrier inhibitors for breast cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110486"}}